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Introduction
An increase in physical activity level is an important goal in the 
rehabilitation of patients with chronic heart failure (CHF).1,2 
It has been shown that exercise training can improve peak aer-
obic power (VO peak2 ),
3,4 muscle strength and mass,3–5 New York 
Heart Association (NYHA) functional class,6 and quality of 
life7 in this population.
Most existing CHF management recommendations are 
based on information obtained from patients with reduced 
(heart failure with reduced ejection fraction, HFREF) rather 
than preserved (heart failure with preserved ejection fraction, 
HFPEF) ejection fraction. However, it is now well established 
that at least one-half of the patients presenting with symptoms 
and signs of CHF will have a normal left ventricular ejec-
tion fraction (LVEF).8–10 Apart from some limited evidence 
that exercise might improve VO peak2  in patients with HFPEF,
11 
there is no data for improvement in other clinical, functional, 
or psychological parameters. This study will examine the 
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AbstrAct 
IntroductIon: This study will examine the effects of combined aerobic and resistance training on left ventricular remodeling in diabetic patients 
with diastolic dysfunction. This is the first randomized controlled trial to look for effects of combined strength training and aerobic exercise on myocardial 
function as well as other clinical, functional, or psychological parameters in diabetic patients with isolated diastolic dysfunction, and will provide important 
insights into the potential management strategies for heart failure with preserved ejection fraction.
Methods And AnAlysIs: This is a prospective, randomized controlled investigator initiated single center trial. Diabetic patients with LV diastolic 
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exercises, or supervised light stretching (control arm). Pre and post intervention assessment will include stress echocardiography, peak aerobic power with 
12-lead ECG, dual-energy X-ray absorptiometry, muscle strength, the capacity to perform activities of daily living (ADLs), and questionnaires to assess 
self-perceived quality of life and symptoms of depression. The primary endpoint is to compare any change in tissue Doppler-derived LV systolic and early 
diastolic velocities.
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effects of combined aerobic and resistance training on left 
ventricular remodeling in a diabetic population with diastolic 
dysfunction.
Methods. This is a prospective, randomized controlled 
investigator initiated single center trial based at Austin 
Hospital in Melbourne (Australia), where the patients will be 
recruited from. Diabetic patients with LV diastolic dysfunc-
tion suitable for exercise training intervention will be included 
according to the inclusion and exclusion criteria specified in 
Table 1. Patients will be randomized to three months of either 
a training (exercise) or control (stretching) group after base-
line stress echocardiography to exclude patients with coronary 
artery disease. Echocardiography assessment of LV systolic 
and diastolic velocities will be done in a blinded fashion 
(exercise vs. stretching group, as well as the baseline values) 
to evaluate the effects of the exercise program on myocardial 
function.
Primary endpoint. Change in tissue Doppler-derived 
LV systolic (sm) and early diastolic (em) velocities after three 
months of exercise intervention will be the primary end 
point.
Secondary endpoints. Secondary endpoints will be the 
comparison of the difference in peak aerobic power (VO peak2 ), (NYHA) class, diastolic function grades, glycated hemoglo-
bin (HbA1c), LV filling pressure estimate (septal, lateral, and 
average E/e’) at rest and post exercise, LV torsion post exer-
cise, LA volume index, systolic pulmonary artery pressure, 
skeletal muscle inflammatory markers, sodium—potassium 
(Na/K) regulation, and insulin-signaling proteins.
Procedures. At baseline and after three months of inter-
vention, participants will undergo the following assessments: 
stress echocardiography, peak aerobic power with 12-lead 
ECG, dual-energy X-ray absorptiometry (DXA), muscle 
strength, the capacity to perform activities of daily living 
(ADLs), and questionnaires to assess self-perceived quality of 
life and symptoms of depression. In addition, participants will 
be asked to undergo an optional skeletal muscle biopsy.
Stress echocardiogram. All eligible participants will undergo 
pre and post intervention evaluation of diastolic function with 
conventional and the echocardiography imaging when they 
are in a stable state. Exercise stress echocardiography will be 
performed using symptom-limited graded exercise on a Cybex 
MET 100 cycle (Cybex Metabolic Systems, Ronkonkoma, 
NY, USA). Exercise capacity will be measured in metabolic 
equivalents (MET) and VO2. Images of the left ventricle in motion and hemodynamic measures will be recorded at rest 
and immediately after exercise.
Peak aerobic power with 12-lead ECG. Aerobic power 
(VO peak2 ) will be assessed during the same symptom-limited graded exercise test performed for stress echocardiography. The 
test will start after a five-minute period of rest. The protocol 
will consist of an initial intensity of 25 W, then an increase to 
40 W after one minute, followed by increments of 20 W min-
ute−1 for males and 10 W minute−1 for females. The test will be 
terminated when a participant’s rating of perceived exertion 
will reach “very hard” (Borg scale = 17),12 or before that if 
clinical signs or symptoms of metabolic or cardio-respiratory 
abnormalities appear. Expired respiratory gases will be col-
lected through a breath-by-breath (BxB) pneumotach system 
connected to gas analyzers. The BxB data will be integrated for 
each 15 second interval, and the mean values for VO2, VCO peak2 , and ventilation (VE) used for that interval were calculated. 
The gas analyzer will be calibrated immediately before each 
test using gases that had been calibrated at alpha standard. 
Heart rate will be measured at rest and during the incremen-
tal test by 12-lead electrocardiography (Mortara, X-Scribe II, 
Milwaukee, WI, USA). Participants will be asked not to con-
sume caffeine or alcohol for a minimum of two hours before 
the exercise test.
Dual-energy X-ray absorptiometry. DXA (GE Lunar 
Pxodigy, Software version 9.1, Madison, USA) will be used 
to assess total body fat percentages, total body fat, and lean 
body mass (LBM). In addition, the DXA and GE Lunar Pxo-
digy software will be used to assess fat mass in the abdominal 
region. The lower boundary of the abdominal region is defined 
as the pelvis cut. The upper boundary of the abdominal region 
is defined as 20% of the distance between pelvis and neck cut 
above the pelvis cut. All DXA measurements will be conducted 
by the staff at the Bone Density Unit, Repatriation Hospital, 
Austin Health. DXA is a fast, simple, and safe technique to 
evaluate body composition.13 Although DXA was initially 
designed as a tool for the diagnosis of osteoporosis, it has been 
recognized also as a precise tool to evaluate fat and LBM.14,15
Exercise training. Participants will be randomized to 
three months of either a combination of resistance and aero-
bic training (exercise) or control (stretching). Both groups will 
train for three days/week under the supervision of an exer-
cise physiologist. For the EXERCISE group, sessions will 
begin with five minutes of warm-up followed by 50 minutes 
of exercises (30 minutes aerobic and 20 minutes power), and 
5 minutes of cool-down. Aerobic exercise intensity will be at 
Table 1. inclusion and exclusion criteria.
inCLuSion CRiTERia ExCLuSion CRiTERia
•	 type 2 diabetes mellitus
•	 Peak early diastolic  
myocardial tissue velocity  
(septal e’) ,8 cm/s
•	 deceleration time 
(dt) .220 msec or e/e' .10
•	 age 18 years or older
•	 Known coronary artery  
disease or evidence of  
ischaemia on baseline  
stress echocardiography
•	 left ventricular ejection  
fraction ,45%
•	 Significant (moderate or  
severe) valvular disease
•	 Unstable heart failure  
requiring .2 medication  
changes in last 3 months
•	 Unstable diabetes as  
evidenced by hypoglycaemic 
events .1/week, or hba1c  
$9.0%
•	 Atrial fibrillation
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70–75% of the predetermined VO peak2 . Resistance exercise: three different exercises using large muscle groups (chest, back, legs, 
and shoulders). Each exercise will be performed for three sets, 
8–12 repetitions. During the first week, intensity will corre-
spond to 60% one-repetition maximum test (1RM). At week 2, 
intensity will increase to 70% 1RM and from week 3 to 16, 
intensity corresponded to 70–75% 1RM. For each session, 
weights will be adjusted according to the current capacity of 
the individual. Participants will rest for 120 seconds between 
sets and for 120–150 seconds between exercises. Blood sugar 
levels (BSL) will be monitored by checking the levels before 
and after each session. The STRETCHING (control) group 
will perform 60 minutes of light stretching (sham exercise 
group).
Muscle strength. Four to eight days prior to the 1RM, par-
ticipants will perform a familiarization session with the resis-
tance training equipment. During the familiarization session, 
correct lifting and breathing techniques will be taught and 
practiced using sub-maximal and near maximal loads. 1RM 
is defined as the heaviest weight a participant is able to lift 
once, using a proper lifting technique, without compensatory 
movements.16 1RM strength will be assessed for two differ-
ent exercises, including chest press and leg press. The tests 
will commence after a light warm-up (three-minute walking 
at self-selected speeds on a treadmill). The maximal strength 
test protocol includes one set of 10 repetitions at a relatively 
light load that serves as a specific warm-up, followed by a 
gradual increase in load until 1RM is achieved. The rate of 
the gradual increase in load will be dependent on the partici-
pant’s self-perceived capacity. 1RM will be achieved within 
three to eight attempts. The rest period between attempts 
will be 60 seconds, and 120 seconds between each specific 
exercise. Studies have reported that 1RM method to assess 
muscle strength is safe for the elderly17,18 and patients with 
cardiovascular disease (CVD).19,20 1RM test is reliable21 and 
the protocol has been used previously by us to evaluate maxi-
mal strength in patients with CHF22,23 and patients at a high 
risk for developing diabetes and CVD.24
Functional tests. The functional tests will be based on the 
methods of Reuben and Siu, with modifications by Brandon 
et al. and Nichols et al.25–27 Participants will perform four 
tasks that represent ADLs: 15 m rapid walking test, chair rise 
test, walking up stairs, and walking down stairs. In the 15 m 
rapid walking test, the participant will be asked to cover the 
distance as fast as he/she can but at a safe pace. In the chair 
rise test, the participant will be asked to rise from a chair, walk 
3 m, and return to the chair. The walking up and down stairs 
test will consist of climbing up and down 20 steps “as fast as 
possible” while carrying a weight that corresponds to 10% of 
their body weight, but in a comfortable and safe manner.24,28
Questionnaires. Short Form Healthy Survey (SF 36) and 
the Cardiac Depression Scale (CDS) will be completed before 
and after three months of intervention. We have used these 
questionnaires previously.24
Muscle biopsy (optional). Muscle biopsies will be taken 
from the vastus lateralis by a medical practitioner experienced 
in the technique before and after the three months of train-
ing. Histochemical and protein analysis will be used to deter-
mine muscle inflammatory markers, Na/K, insulin-signaling 
proteins, other proteins, and enzymes that regulate muscle 
function.
randomization. Randomization will take place imme-
diately after the collection of baseline data is completed. The 
twenty patients will be allocated to exercise or stretching 
groups according to computer generated random numbers 
held in sealed envelopes by a third party. The randomization 
will be stratified according to muscle biopsy/no muscle biopsy 
and balanced after every two patients using the method of 
Peto et al.29
sample size. The sample size for the fully powered ran-
domized controlled trial (RCT) will be 48 participants for the 
intervention group, taking into account our preliminary data 
where the em = 6.6 ± 1.6 (cm/second), and assuming that we 
achieve an expected 15% change in the myocardial measures 
(indicated by a difference in myocardial torsion or diastolic 
tissue velocities) in response to intervention, it is estimated 
that a minimum of 44 subjects will be required in each group 
to deliver a statistical power greater than 0.8 with a P-value of 
,0.05. A total of 48 subjects will be enrolled in the treatment 
arm to account for an anticipated dropout of 10%. A pilot 
study will be conducted initially with an estimated enrollment 
of 20 patients to assess the preliminary results before continu-
ing further enrollment.
statistical analysis. All patients who undergo 
randomization will be included in the primary analy-
sis in the groups to which they were originally allocated 
(intention-to-treat principle). Multivariate analysis of vari-
ance (MANOVA) will be used to examine physiological 
and functional differences between groups at baseline. 
A repeated measure ANOVA model will be used to analyze 
the effect of primary interest by time (pre, post), treatment 
(training and control), and time-by-treatment (effect over 
time). A Spearman rho correlation will be conducted to 
assess the relationship between selected variables. Paired 
t-test will be used to compare pre and post training echo 
values. Data will be reported as mean ± standard deviation 
(SD) and all statistical analyses will be conducted at the 
95% level of significance.
ethical considerations. The study will be performed 
in accordance with the Declaration of Helsinki. The proto-
col, informed consent form, and other study-related docu-
ments were submitted to the local Human Research Ethics 
Committee and approved. A written informed consent was 
obtained from each participant. The trial has been regis-
tered in the Australian New Zealand Clinical Trials Registry 
(ANZCTR) with a trial ID ACTRN12610000943044. The 
investigator, regardless of the outcome, will publish the results 
of the study.
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discussion
Exercise training can restore the abnormal autonomic, 
neurohormonal, hemodynamic, and functional abnormali-
ties in patients with HFREF.3,6,30,31 Some investigators 
have shown that exercise can reverse LV remodeling in 
clinically stable HFREF patients,32 that is, the left ventricle 
can again become smaller and contract more efficiently. One 
recent study11 showed improvement of diastolic function in 
subgroups of patients with significant increase in moder-
ate and vigorous activity, after one year of supervised and 
home based exercise intervention. However other investiga-
tors33,34 have reported no benefits with exercise training on 
LV end-diastolic volume, end-systolic volume, or ejection 
fraction. Thus, uncertainty remains regarding the effects 
of exercise training on LV remodeling in patients with 
HFPEF.
Aerobic exercise vs. resistance training. There is controversy 
regarding the level and format of exercise that can yield opti-
mal beneficial effects in CHF. Exercise intensity has been 
reported as an important factor for reversing LV remodeling 
and improving aerobic capacity.35 Similarly, resistance train-
ing has been shown to be safe and to improve skeletal muscle 
strength, peak oxygen consumption, and quality of life in 
patients with CHF.5,22,36 However a recent meta-analysis37 of 
14 randomized trials to determine the effect of exercise train-
ing and type of exercise (aerobic vs. strength vs. combined 
training) on LV remodeling in clinically stable patients with 
HFREF indicated no confirmed benefit with combined aero-
bic and strength training despite reversal of LV remodeling 
with aerobic training.
Heart failure and diabetes. LV systolic and diastolic dys-
function is a common feature in patients with type 2 dia-
betes mellitus (T2DM).38 A recent RCT11 investigated 
the effects of a one-year exercise intervention and failed to 
improve myocardial function in all patients. However, post-
hoc analysis revealed that subgroups of patients who had 
the greatest increases in both moderate and vigorous activ-
ity significantly improved diastolic function, HbA1c, and 
cardio-respiratory fitness. This study involved an unselected 
group of patients since absence of LV dysfunction was not an 
exclusion criterion, which may have contributed to the lack 
of overall effect of the intervention on myocardial function. 
Furthermore, although based on current recommendations, 
the prescription used in this study may have had insufficient 
training dose (volume or intensity) to yield improvements in 
myocardial function in all subjects, when compared to some 
other studies.39–43
Doppler tissue imaging and 2D speckle tracking. 2D speckle 
tracking is a new technique that is able to quantify circum-
ferential and radial motion, validated non-invasively by mag-
netic resonance imaging (MRI) tagging and invasively by 
sonomicrometry in animal models.44–46 New developments 
in echocardiography enable a much fuller assessment of LV 
systolic and diastolic function, including measurement of 
myocardial deformation or strain.44,45,47 Stress echocardiog-
raphy using these newer techniques to assess LV tissue veloci-
ties, strain, and torsion has been shown to have increased 
sensitivity to predict diastolic dysfunction.45,48–50
Skeletal muscle function and metabolism. The most common 
physical symptoms of patients with CHF are fatigue, shortness 
of breath and dyspnea, a decrease in work capacity and exer-
cise intolerance, and muscle atrophy and strength reduction. 
These characteristics may be attributed to the changes in the 
structure, metabolism, and function of skeletal muscles that 
are an integral part of and an inseparable consequence of the 
progression of the disease.51,52 Changes in skeletal muscle may 
also be due to deconditioning and disuse. The level of skeletal 
muscle impairment, the deficit in the skeletal muscle blood 
flow, and exercise intolerance are influenced by the severity of 
the MI and LV dysfunction.
People with type 2 diabetes also have altered muscle 
metabolism. It has been reported that the bioenergetic capacity 
of skeletal muscle mitochondria is impaired in patients with 
T2DM, compared to lean individuals. There is substantial 
evidence to indicate that alterations in skeletal muscle fiber 
types, mainly a reduction in percentage of type I fibers and 
an increase in percentage of type II fibers, are associated with 
obesity and T2DM. Studies have revealed that individuals 
with higher fat mass have higher percentages of fast twitch 
fiber types and lower percentages of type I fibers. As type I 
fibers are characterized by high capillary density, lipid storage 
capacity, insulin binding, insulin-stimulated glucose uptake, 
high GLUT4 content, and high oxidative enzyme activities, a 
reduction in type I fibers may contribute to prolonged recov-
ery from peak exercise and early fatigue in obese patients and 
those with T2DM. Therefore, we will examine whether exer-
cise training can, at least in part, restore muscle function and/
or muscle metabolism.
conclusion
This is the first randomized controlled trial to look for the 
effects of combined strength training and aerobic exercise on 
myocardial function as well as other clinical, functional, or 
psychological parameters in diabetic patients with isolated 
diastolic dysfunction, and will provide important insights into 
the potential management strategies for HFPEF.
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